The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.

Publications

644 Publications Available

October 12, 2020

Functional precision medicine identifies new therapeutic candidates for medulloblastoma

Cancer Research

October 05, 2020

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

The Journal of Clinical Investigation

October 01, 2020

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer

EBioMedicine

September 28, 2020

Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma

JCO Precision Oncology

September 14, 2020

Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses

Nature Biotechnology

September 07, 2020

Cancer cells educate natural killer cells to a metastasis-promoting cell state

J Cell Biol.

September 03, 2020

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Cell

September 01, 2020

Plasticity of ether lipids promotes ferroptosis susceptibility and evasion

Nature

September 01, 2020

High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients

Journal of Translational Medicine

August 20, 2020

The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Nat Immunol.